Chloride Channels - New Targets for the Prevention of Stroke

被引:11
|
作者
Du, Yan-Hua [1 ]
Guan, Yong-Yuan [1 ]
机构
[1] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Cardiac & Cerebral Vasc Res Ctr, Guangzhou 510080, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
CIC-3; TMEM16A; cerebral vascular remodeling; stroke; proliferation; apoptosis; inflammation; BLOOD-PRESSURE REDUCTION; CELL-VOLUME REGULATION; OF-NEUROLOGY AFFIRMS; ACTIVATED CL-CURRENT; SMOOTH-MUSCLE-CELLS; FACTOR-KAPPA-B; ISCHEMIC-STROKE; NADPH OXIDASE; VASCULAR EVENTS; STATIN THERAPY;
D O I
10.2174/1570161112666141014145040
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Stroke is a leading cause of morbidity and mortality worldwide. It has been generally accepted that cerebrovascular remodeling during hypertension is one of the major contributors to the increased risk of stroke. Volume-regulated Cl- channel (VRCC) and calcium-activated Cl- channel (CaCC) are the two predominant types of Cl- channels in cerebral vascular smooth muscle cells (VSMC). Recent studies have demonstrated that ClC-3, a member of the voltage-gated ClC Cl- channel family, is the molecular candidate for VRCC in VSMC. And TMEM16A, a member of anoctamin family, is responsible for the native CaCC of VSMC in brain vessels. It has been shown that VRCC activity is enhanced but CaCC activity is decreased in cerebral VSMC, paralleling the severity of cerebrovascular remodeling induced by hypertension. In the present review, we will highlight the recent findings regarding the important roles of these two channels in VSMC proliferation, apoptosis, cell cycle regulation, vascular inflammation, reactive oxygen species production and cerebrovascular remodeling during the development of hypertension. In addition, the relationship between VRCC and clinical used agents for stroke prevention, such as statins, will be discussed. These findings suggest that Cl- channels may be potential new targets for the prevention of stroke.
引用
收藏
页码:441 / 448
页数:8
相关论文
共 50 条
  • [41] Secondary prevention of stroke - New trials
    Forbes, CD
    SCOTTISH MEDICAL JOURNAL, 1998, 43 (01) : 5 - 6
  • [42] New targets for the prevention of transplant vascular disease
    Häyry, P
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (03) : 2332 - 2333
  • [43] Incretins: new targets for the prevention of diabetes and obesity
    Neff, Karl J.
    le Roux, Carel W.
    CLINICAL LIPIDOLOGY, 2013, 8 (01) : 109 - 121
  • [44] Quality of Stroke Prevention Care in Atrial Fibrillation Many Moving Targets
    Turakhia, Mintu P.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (01): : 5 - 8
  • [45] Stroke Prevention: From Available Antiplatelet Drugs to Novel Molecular Targets
    Di Minno, Matteo Nicola Dario
    Momi, Stefania
    Di Minno, Alessandro
    Russolillo, Anna
    CURRENT DRUG TARGETS, 2013, 14 (01) : 3 - 12
  • [46] Cardiac sodium channels as targets for new inotropic agents
    Steinberg M.I.
    McCall E.
    Mest H.-J.
    Raap A.
    Wright T.
    Heart Failure Reviews, 1998, 2 (3) : 173 - 193
  • [47] HCN Channels: New Therapeutic Targets for Pain Treatment
    Ramirez, David
    Zuniga, Rafael
    Concha, Guierdy
    Zuniga, Leandro
    MOLECULES, 2018, 23 (09):
  • [48] A new model for secondary prevention of stroke: transition coaching for stroke
    Bushnell, Cheryl
    Arnan, Martinson
    Han, Sangwon
    FRONTIERS IN NEUROLOGY, 2014, 5
  • [49] Stroke, cholesterol and statins: are there new data about stroke prevention?
    Ferbert, A
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (22) : 664 - 670
  • [50] TRP channels in COVID-19 disease: Potential targets for prevention and treatment
    Jaffal, Sahar M.
    Abbas, Manal A.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2021, 345